Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol and Brain Insulin Action
NCT07109245Phase 4Recruiting
- Sponsor
- Center for Addiction and Mental Health
- Start
- Dec 2025
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of haloperidol in schizophrenia, sponsored by Center for Addiction and Mental Health. Started Dec 2025; status: recruiting.
02
Drugs
haloperidol
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT07109245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07109245.